Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study

Martin-Hirsch, 2010, Surgery for cervical intraepithelial neoplasia, Cochrane Database Syst Rev, 6, 10.1002/14651858.CD001318.pub2

Zielinski, 2004, HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis, Obstet Gynecol Surv, 59, 543, 10.1097/00006254-200407000-00024

Melnikow, 2009, Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study, J Natl Cancer Inst, 101, 721, 10.1093/jnci/djp089

Soutter, 2006, Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia, Int J Cancer, 118, 2048, 10.1002/ijc.21604

Kreimer, 2006, Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease, Cancer Epidemiol Biomarkers Prev, 15, 908, 10.1158/1055-9965.EPI-05-0845

Paraskevaidis, 2004, The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature, Cancer Treat Rev, 30, 205, 10.1016/j.ctrv.2003.07.008

Prato, 2008, Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions, Int J Gynecol Cancer, 18, 90, 10.1111/j.1525-1438.2007.00965.x

Wright, 2007, 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ, Am J Obstet Gynecol, 197, 340, 10.1016/j.ajog.2007.07.050

Kyrgiou, 2006, The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach, Cancer Treat Rev, 32, 516, 10.1016/j.ctrv.2006.07.008

Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

Nobbenhuis, 2001, Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia, Br J Cancer, 84, 796, 10.1054/bjoc.2000.1689

Elfgren, 2002, Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia, Obstet Gynecol, 100, 965, 10.1016/S0029-7844(02)02280-9

Alonso, 2006, Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3, Gynecol Oncol, 103, 631, 10.1016/j.ygyno.2006.04.016

Kitchener, 2008, HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia, BJOG, 115, 1001, 10.1111/j.1471-0528.2008.01748.x

Bais, 2009, Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease, Int J Cancer, 124, 889, 10.1002/ijc.23824

Coupe, 2007, Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia, BJOG, 114, 416, 10.1111/j.1471-0528.2007.01265.x

Strander, 2007, Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study, BMJ, 335, 1077, 10.1136/bmj.39363.471806.BE

Hogewoning, 2003, Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial, Int J Cancer, 107, 811, 10.1002/ijc.11474

Brink, 2006, High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush, J Clin Microbiol, 44, 2518, 10.1128/JCM.02440-05

Petignat, 2007, Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis, Gynecol Oncol, 105, 530, 10.1016/j.ygyno.2007.01.023

Bulk, 2004, The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996, J Clin Pathol, 57, 388, 10.1136/jcp.2003.011841

van den Brule, 2002, GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes, J Clin Microbiol, 40, 779, 10.1128/JCM.40.3.779-787.2002

Snijders, 2005, HPV DNA detection and typing in cervical scrapes, Methods Mol Med, 119, 101

Wright, 1995, Precancerous lesions of the cervix, 248

Turnbull, 1976, The empirical distribution function with arbitrarily grouped, censored and truncated data, J R Stat Soc Series B, 38, 290

Sun, 1996, A non-parametric test for interval-censored failure time data with application to AIDS studies, Stat Med, 15, 1387, 10.1002/(SICI)1097-0258(19960715)15:13<1387::AID-SIM268>3.0.CO;2-R

Fay, 2010, Exact and asymptotic weighted logrank tests for interval censored data: the interval R package, J Stat Softw, 36, 1, 10.18637/jss.v036.i02

2010

Chan, 2009, Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review, Am J Obstet Gynecol, 200, 422e1, 10.1016/j.ajog.2008.11.031

Arbyn, 2005, Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence, Gynecol Oncol, 99, S7, 10.1016/j.ygyno.2005.07.033

Arbyn, 2006, Chapter 9: clinical applications of HPV testing: a summary of meta-analyses, Vaccine, 24, 78, 10.1016/j.vaccine.2006.05.117

Bulkmans, 2007, Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, Lancet, 370, 1764, 10.1016/S0140-6736(07)61450-0

Strander, 2007, Does HPV-status 6–12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?, Eur J Cancer, 43, 1849, 10.1016/j.ejca.2007.05.016

Castle, 2007, Risk assessment to guide the prevention of cervical cancer, Am J Obstet Gynecol, 197, 356e1, 10.1016/j.ajog.2007.07.049